Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

Clinical trial NCT05998135 · RECRUITING

Trial details

NCT number: NCT05998135
Sponsor: Emory University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian High Grade Serous Adenocarcinoma Platinum-Resistant Ovarian Carcinoma

Start date: 2023-11-09
Primary completion: 2026-06-30
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.